Full-Time

Associate Director Global IT Business Partner

Commercial

Posted on 2/21/2025

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$139.2k - $174kAnnually

+ Discretionary Bonus + Equity Awards

Senior, Expert

San Diego, CA, USA

This position requires in-office work three days per week on average.

Category
IT Project Management
IT & Security
Required Skills
Data Analysis

You match the following Acadia Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in Information Systems or equivalent technical discipline
  • A minimum of 10 years progressively responsible experience ideally in the pharmaceutical and/or life sciences industry
  • Proven ability to partner with business management in developing and implementing technology strategy
  • Ability to work with all levels of the organization, both technical and non-technical
  • Solid domain knowledge of business processes and related data types in applicable business domain area to support technology solutions
  • Ability to be highly organized, self-motivated with the capability to prioritize projects and workload
  • Skilled at effectively leading IT projects with cross functional team effort and organizing resources to achieve project goals
  • Adaptability to quickly and proactively implement change initiatives
  • Ability to deal with ambiguity and the corresponding capacity to make decisions or recommendations based on potentially incomplete information
  • Excellent attention to detail
  • Excellent interpersonal and communications skills in both a business context and an IT context, including tact, diplomacy and flexibility
  • Experience with operational systems support for key systems providing issue resolution through internal resources and vendor support
  • Experience with standard systems development life cycle (SDLC) and SaaS deployment models
Responsibilities
  • Act as the primary face of IT for an assigned business domain including planning, conducting, coordinating, and communicating IT operational plans and policy
  • Support IT project management in the implementation of technology solutions according to Acadia’s IT governance processes, including intake assessment and standard PMO reporting
  • Act as operational lead for specific business domain systems including holding recurring operational meetings with business partners and vendors, tracking and evaluating change requests, initiating change controls for implementation of changes, coordinating routine system patches and escalating issues as appropriate
  • Work with other business partners to establish and enhance cohesive relationships with business stakeholders and establish Acadia’s overall systems roadmap
  • Work with Business to help define and document business processes and requirements including, but not limited to, data flow, data storage, application usability, infrastructure, reporting and analytics
  • Facilitate RFP initiatives for evaluating new technology solutions
  • Perform vendor management activities such as establishing contracts (e.g., NDA, MSA, SOW) and managing ongoing licensing and renewals
  • Oversee maintenance of standard operating procedures and periodic review activities for domain systems and process
  • Oversee user acceptance testing activities with business partners
  • Oversee computer systems validation activities adhering to 21 CFR Part 11 guidelines (if applicable), and/or other regulatory requirements
  • Provide configuration support for key systems, if required
Desired Qualifications
  • PMP certification
  • Experience working in a regulated environment following GxP processes (if applicable)
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, which are then approved by regulatory bodies like the FDA before being sold to patients and healthcare providers. What sets Acadia apart from competitors is its long-standing commitment to addressing unmet medical needs in neuroscience, along with its emphasis on corporate social responsibility, including diversity and inclusion. The goal of Acadia Pharmaceuticals is to improve the quality of life for individuals suffering from challenging neurological diseases through effective treatments.

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's recent Health Canada approval for Daybue boosts its market presence in Canada.
  • The exclusive license agreement with Saniona expands Acadia's drug portfolio with SAN711.
  • Hiring Thomas Andrew Garner as CCO strengthens Acadia's commercial leadership team.

What critics are saying

  • Increased competition in CNS drugs may impact Acadia's market share and growth.
  • Regulatory challenges could delay or prevent new drug approvals, affecting revenue.
  • High drug development costs may strain financial resources if trials are unsuccessful.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on unmet needs in neurological disorders like Parkinson's and Rett syndrome.
  • The company has a strong R&D pipeline with four product candidates in development.
  • Acadia collaborates with partners like Biovail to enhance drug development and commercialization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Company News

Fierce Pharma
Dec 9th, 2024
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO).

MarketWatch
Nov 26th, 2024
Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

World Pharmaceuticals
Oct 17th, 2024
Acadia gets Health Canada approval for Daybue to treat Rett Syndrome

US-based biopharmaceutical company Acadia Pharmaceuticals has received Health Canada marketing authorisation for Daybue (trofinetide) to treat a rare genetic neurological disorder.

PRWeb
Aug 23rd, 2024
Global Genes' Annual Week In Rare Event Heading To Kansas City

"Week in RARE provides advocates a unique opportunity to participate in multiple events in one place to maximize their time, travel, and potential to gain benefits from their participation."

Yahoo Finance
Aug 15th, 2024
Ryan Reynolds Announces More To Parkinson'S(R) Campaign

Ryan & Tammy Reynolds (Photo: Business Wire)Acadia Parkinson's Fact Sheet-- The national disease awareness campaign aims to educate and drive conversation about recognizing and managing non-motor symptoms of Parkinson’s, including hallucinations and delusions-- Reynolds and his mother Tammy share their personal story about the impact of these symptoms on their familySAN DIEGO, August 14, 2024--(BUSINESS WIRE)--Ryan Reynolds, a world-renowned actor/entrepreneur and Parkinson’s disease advocate, with Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the launch of a multi-faceted disease education campaign, More to Parkinson’s®, to raise awareness among caregivers, patients and their care providers about a common, yet under-recognized aspect of Parkinson’s disease – Parkinson’s-related hallucinations and delusions.Notably, around half of the people living with Parkinson’s disease may develop hallucinations or delusions over the course of their disease, but up to 90% of people currently do not proactively tell their physicians about these symptoms.1-3 By sharing their experiences caring for Ryan’s father, James "Jim" Reynolds, who passed away nearly a decade ago, Ryan and his mother Tammy, aim to raise awareness, educate and drive conversation between people with Parkinson’s disease, their families and their doctors about how best to talk about and treat these non-motor symptoms."My father experienced hallucinations and delusions. At the time, we didn’t know any of these types of symptoms were part of his Parkinson’s disease," Reynolds explains. "Like a lot of caregivers, my mom mostly tried to carry these burdens alone. I wish I’d known Parkinson’s disease wasn’t limited to only motor symptoms. I think people and families affected by Parkinson’s can be better prepared to manage hallucinations and delusions if they’re talking early and often about this lesser-known aspect of the disease."This press release features multimedia